MedCity News

From Benefits to Protection: Medical Debt Belongs in Employer Strategy

Medicare Patients Don’t Need More Information —They Need Someone to Act

The assumption is intuitive and well-intentioned: if patients simply understood the system better, they would use it more effectively. However, for most Medicare patients, that assumption is wrong. The barrier to care isn't knowledge, it's execution.

By Sam Wu

MedCity Influencers

Digital generated image of dollar sign lying on a medical couch visualizing crisis and loss.

The Hidden Million-Dollar Problem Lurking in Hospital Operations

As the industry continues to pour money into AI and other emerging technologies, a more disciplined era of healthcare technology investment is taking shape.

By Guy Yehiav and Edward Marx

Devices & Diagnostics, Health Tech

Oura Files for IPO As Healthcare Ambitions Grow

Oura has filed for an IPO as it looks to build on its evolution from a sleep-focused wearable startup into a broader healthcare player.

By Katie Adams

Latest Video

Latest News

Health Tech, Consumer / Employer

A robot hand and a doctor's hand with a medical technology icon. A concept for human and AI collaboration in healthcare, robotic-assisted surgery, and the future of medicine.

Employers are Scaling AI Use in Health Benefits, but Face Challenges

A new WTW survey found that employers are rapidly adopting AI in health benefits despite concerns about governance, resources, privacy and compliance.

By Marissa Plescia

BioPharma, Pharma

Eli Lilly’s Vaccine Acquisitions Signal a Strategy of Growth in New Areas

Eli Lilly is spending up to $3.8 billion to buy vaccines in development for shingles, staph infections, and Epstein-Barr virus as well as the platform technologies that spawned these programs. The pharmaceutical giant indicated interest in infectious disease last year when it hired Peter Marks, former director of the FDA division that oversees vaccines.

By Frank Vinluan

MedCity Influencers

Digital Health Keeps Measuring Engagement While Ignoring Tolerability

Engagement still matters. But the more important question is whether the intervention respects the human nervous system of the person on the receiving end.

By Nargiz Noimann

MedCity Influencers

AI Health Check: No Governance, No Trust

Will doctors or patients who are burned by one AI solution trust the next one they’re given? Probably not. That’s why every provider rolling out AI tools has to understand this risk and build governance into its development process.

By Luiz Cieslak

MedCity Influencers

The Silent Threat — Why Early Lymphedema Detection Matters for Breast Cancer Survivors

As breast cancer treatment continues to improve, our focus must expand beyond survival to encompass the quality of life during and after treatment.

By Dr. Steven Chen

BioPharma, Pharma

AstraZeneca, Daiichi Drug Approved as New First-Line Therapy for Tough Type of Breast Cancer

Datroway landed its third FDA approval in the past 18 months, this time as a treatment for triple negative breast cancer. The antibody drug conjugate was developed under a broad collaboration between Daiichi Sankyo and AstraZeneca.

By Frank Vinluan

BioPharma, Hospitals, Devices & Diagnostics, Health Tech, Providers

Precision Medicine’s Next Hurdle Isn’t Science — It’s Execution

A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and patient engagement issues. Health system leaders say the field’s future depends on embedding genomics into routine care, as well as proving its clinical and financial value.

By Katie Adams

The Power Behind Enterprise EHR Software for Large Healthcare Systems

Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.

By Malvika Tarnekar, Director of Product Strategy, PrognoCIS by Bizmatics Inc

MedCity Influencers

Maximizing Value vs. Minimizing Cost in Healthcare Purchasing

Is a private-label product really better once you factor in performance, durability, and everything it takes to support it? Sometimes yes and sometimes no. The job is knowing the difference.

By Jonathan Treiber

MedCity Influencers

What the Failure of Wearables Can Teach Us About AI

The takeaway from the current failure of wearables is that signal without synthesis doesn't change outcomes. If healthcare treats AI as just another way to collect or repackage data, it will repeat the same mistake.

By David Kirk

MedCity Influencers

Clinical Operations Burnout Is Undermining Patient Enrollment

When coordinators are buried in documentation, scheduling, and data reconciliation, patient engagement is the first thing to go. And when engagement drops, retention drops with it.

By Scott Chetham

MedCity Influencers

Smarter Engagement for Stronger Growth: How Payers Can Successfully Do More with Less

The defining capability of modern health plans is intelligent engagement with unified infrastructure.

By Steve Mongelli

MedCity Influencers

AI Is Becoming the Front Door to Healthcare — But Millions of Patients Can’t Get Through It

AI genuinely could reduce barriers, by making health information more conversational, more personalized, and easier to act on. But that only happens if the people building these tools decide, from day one, that accessibility isn’t optional.

By Mike Barton

MedCity Influencers

AI Made Healthcare Smarter – The Next Step is Making It Simpler

A newly diagnosed person experiences healthcare as a complicated maze of physicians, specialists, pharmacies, insurers, deductibles, formularies, prior authorizations, benefit explanations and coverage rules that rarely speak to one another and often contradict each other. Better AI can help.

By Sage Khanuja

Hospitals

Digital balancing scale justice, fairness in modern technology environment. Holographic scales balance on illuminated datum background of ai circuitry. Innovation concept in abstract futuristic

Hospitals Take CVS to Court Over Alleged $250M 340B Scheme

Three health systems — Mount Sinai, Michigan Medicine and the University of Kansas Health System — are suing CVS Health, alleging its pharmacy benefit manager diverted roughly $250 million in savings from the 340B program through “spread pricing” between 2020 and 2025.

By Katie Adams

Pharma, Legal

Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case

Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict.

By Frank Vinluan